Invention Grant
- Patent Title: Glutamate dehydrogenase mutant and application thereof
-
Application No.: US16684509Application Date: 2019-11-14
-
Publication No.: US11339380B2Publication Date: 2022-05-24
- Inventor: Lirong Yang , Xinjian Yin , Jianping Wu , Gang Xu
- Applicant: ZHEJIANG UNIVERSITY
- Applicant Address: CN Zhejiang
- Assignee: ZHEJIANG UNIVERSITY
- Current Assignee: ZHEJIANG UNIVERSITY
- Current Assignee Address: CN Zhejiang
- Agency: Jacobson Holman PLLC
- Agent Jiwen Chen
- Priority: CN201910403331.2 20190515
- Main IPC: C12N9/04
- IPC: C12N9/04 ; C12N9/06 ; C12N15/74 ; C12P13/00

Abstract:
The invention discloses a glutamate dehydrogenase mutant and an application thereof. The mutant is one of the following: a mutant of the amino acid sequence of SEQ ID NO. 1 which has a mutation at lysine at position 402 to phenylalanine or aspartic acid; a mutant which has a mutation at isoleucine at position 406 to phenylalanine or threonine; a mutant which has a mutation at threonine at position 121 and leucine at position 123; a mutant which has a mutation at alanine at position 379 and leucine at position 383. In the invention, the catalytic activity of glutamate dehydrogenase derived from Pseudomonas putida to 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid (PPO) is significantly improved by a molecular transformation method combining directed evolution and a semi-rational design; and the issue of low glutamate dehydrogenase activity in the process of preparing L-glufosinate by reductive amination is solved.
Information query